Astro-Med Schedules Conference Call to Discuss Divestiture of

Astro-Med Schedules Conference Call to Discuss Divestiture of Grass
Technologies 
WEST WARWICK, RI -- (Marketwire) -- 01/07/13 --  Rhode Island-based
electronics manufacturer Astro-Med, Inc. (NASDAQ: ALOT) issued a
joint press release earlier today with Natus Medical Incorporated
(NASDAQ: BABY) announcing that Astro-Med has entered into a
definitive agreement to sell its Grass Technologies business segment. 
Investor Conference Call 
In conjunction with this release, Astro-Med will host a conference
call on Tuesday, January 8th, 2013 at 11 AM EST. Those wishing to
participate in the call should dial 1-877-941-0844, and enter meeting
ID 4588513. It will also be webcast on the Investing Portion of our
website. 
The Astro-Med, Inc. webcast is also being distributed through the
Thomson StreetEvents Network. Individual investors can listen to the
call at www.earnings.com, Thomson's individual investor portal,
powered by StreetEvents. Institutional investors can access the call
via Thomson StreetEvents (www.streetevents.com), a password-protected
event management site.  
Following the live event, a webcast of the recorded call will be
available for ten days at www.Astro-MedInc.com. A telephone replay of
the conference call will also be available for seven days by dialing
1-800-406-7325 with passcode 4588513.  
About Astro-Med, Inc. 
Astro-Med, Inc. is a leading manufacturer of specialty high tech
printing systems, electronic medical instrumentation, and test and
measurement data acquisition systems. Astro-Med, Inc. products are
sold under the brand names Astro-Med(R) and QuickLabel(R) Systems,
and are employed around the world in a wide range of aerospace,
medical, military, industrial, labeling and packaging applications.
Astro-Med, Inc. is a member of the Russell Microcap(R) Index.
Additional information is available by visiting www.Astro-MedInc.com. 
Safe Harbor Statement 
This news release contains forward-looking statements, and actual
results may vary from those expressed or implied herein. Factors that
could affect these results include those mentioned in Astro-Med's
FY2012 annual report and its annual and quarterly filings with the
Securities and Exchange Commission. 
Contact:
Everett V. Pizzuti
CEO
Joseph P. O'Connell
CFO
Tel: 800-343-4039 
www.Astro-MedInc.com 
 
 
Press spacebar to pause and continue. Press esc to stop.